相似文献/References:
[1]徐万东.基层医疗卫生机构经济运行保障机制研究[J].卫生经济研究,2016,(02):57.
[2]邵 蓉,孙海顺,张 梦.英国短缺药品联络人报告制度对我国的启示[J].卫生经济研究,2016,(12):22.
[3]李 勇,赵梦蕊,马爱霞,等.我国仿制药一致性评价对药品短缺的影响分析[J].卫生经济研究,2017,(05):47.
[4]向国春,陈运山,李婷婷,等.健康扶贫与医疗救助衔接的挑战及探索[J].卫生经济研究,2019,(04):10.
XIANG Guo-chun,CHEN Yun-shan,LI Ting-ting,et al.The Challenge and Exploration of Health Poverty Alleviation and Medical Assistance[J].Journal Press of Health Economics Research,2019,(08):10.
[5]葛 靖,王淑庆,常 峰,等.上海市短缺药品特点及使用变化情况研究[J].卫生经济研究,2020,(02):59.
GE Jing,WANG Shu-qing,CHANG Feng,et al.Study on the Characteristics and Changes of Drugs in Shortage in Shanghai[J].Journal Press of Health Economics Research,2020,(08):59.
[6]朱雅萌,傅鸿鹏.我国短缺药品现状分析与思考[J].卫生经济研究,2021,38(6):59.
ZHU Ya-meng,FU Hong-peng.Analysis and Reflection on the Current Situation of Drug Shortage in China[J].Journal Press of Health Economics Research,2021,38(08):59.
[7]俞心怡,吴 培,胡楠清,等.短缺药品储备政策的实施现状与优化——以江苏省为例[J].卫生经济研究,2021,38(11):29.
YU Xin-yi,WU Pei,HU Nan-qing,et al.Implementation Status and Optimization of Shortage Drug Reserve Policy——A Case Study of Jiangsu Province[J].Journal Press of Health Economics Research,2021,38(08):29.
[8]王秀峰.“建成健康中国”的内涵与保障机制 ——基于对党的二十大精神的学习与思考[J].卫生经济研究,2023,40(3):1.
WANG Xiufeng.The Connotation and Guarantee Mechanism of "Completed Healthy China"——Based on Study and Reflection on the Spirit of the 20th CPC National Congress[J].Journal Press of Health Economics Research,2023,40(08):1.
[9]朱 坤sup>.中国罕见病保障机制：现状、挑战与建议[J].卫生经济研究,2024,41(01):23.
ZHU Kun.Security Mechanism for Rare Diseases in China: Progress，Problems and Suggestions[J].Journal Press of Health Economics Research,2024,41(08):23.
[10]王丽娜,李亦蕾,王煜昊,等.我国短缺药品的采购方式及优化研究[J].卫生经济研究,2024,41(02):36.
WANG Lina,LI Yilei,WANG Yuhao,et al.Study on the Procurement Model and Optimization of Drug Shortage in China[J].Journal Press of Health Economics Research,2024,41(08):36.